nach oben

Current Sexual Health Reports

Erschienen in:

26.10.2019 | Male Sexual Dysfunction and Disorders (A Pastuszak and N Thirumavalavan, Section Editors)

Recent Advances and Future Opportunities to Diagnose Male Infertility

verfasst von: Samantha L. P. Schilit

Erschienen in: Current Sexual Health Reports | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Infertility affects 10–15% of couples, making it one of the most frequent health disorders for individuals of reproductive age. The state of childlessness and efforts to restore fertility cause substantial emotional, social, and financial stress on couples. Male factors contribute to about half of all infertility cases, and yet are understudied relative to female factors. The result is that the majority of men with infertility lack specific causal diagnoses, which serves as a missed opportunity to inform therapies for these couples.

Recent Findings

In this review, we describe current standards for diagnosing male infertility and the various interventions offered to men in response to differential diagnoses. We then discuss recent advances in the field of genetics to identify novel etiologies for formerly unexplained infertility.

Summary

With a specific genetic diagnosis, male factors can be addressed with appropriate reproductive counseling and with potential access to assisted reproductive technologies to improve chances of a healthy pregnancy.

Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99(1):63. https://doi.org/10.1016/j.fertnstert.2012.09.023.CrossRef

Kliesch S. Diagnosis of Male Infertility: Diagnostic work-up of the infertile man. Eur Urol Suppl. 2014;13(4):73–82. https://doi.org/10.1016/j.eursup.2014.08.002.CrossRef

Thornton A, Young-DeMarco L. Four decades of trends in attitudes toward family issues in the United States: the 1960s through the 1990s. J Marriage Fam. 2001;63(4):1009–37. https://doi.org/10.1111/j.1741-3737.2001.01009.x.CrossRef

Williams ME. Toward greater understanding of the psychological effects of infertility on women. Psychother Priv Pract. 1997;16(3):7–26.

Hadley R, Hanley T. Involuntarily childless men and the desire for fatherhood. J Reprod Infant Psyc. 2011;29(1):56–68.CrossRef

Greil AL, Slauson-Blevins K, McQuillan J. The experience of infertility: a review of recent literature. Sociol Health Illn. 2010;32(1):140–62. https://doi.org/10.1111/j.1467-9566.2009.01213.x.CrossRefPubMed

Luk BH, Loke AY. The impact of infertility on the psychological well-being, marital relationships, sexual relationships, and quality of life of couples: a systematic review. J Sex Marital Ther. 2015;41(6):610–25. https://doi.org/10.1080/0092623X.2014.958789.CrossRefPubMed

Gana K, Jakubowska S. Relationship between infertility-related stress and emotional distress and marital satisfaction. J Health Psychol. 2016;21(6):1043–54. https://doi.org/10.1177/1359105314544990.CrossRefPubMed

Luk BHK, Loke AY. Sexual satisfaction, intimacy and relationship of couples undergoing infertility treatment. J Reprod Infant Psychol. 2018;37(2):108–22. 1-15. https://doi.org/10.1080/02646838.2018.1529407.CrossRefPubMed

10.

Ethics Committee of the American Society for Reproductive Medicine. Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion. Fertil Steril. 2015;104(5):1104–10. https://doi.org/10.1016/j.fertnstert.2015.07.1139.CrossRef

11.

Wu AK, Odisho AY, Washington SL 3rd, Katz PP, Smith JF. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort. J Urol. 2014;191(2):427–32. https://doi.org/10.1016/j.juro.2013.08.083.CrossRefPubMed

12.

Chambers GM, Sullivan EA, Ishihara O, Chapman MG, Adamson GD. The economic impact of assisted reproductive technology: a review of selected developed countries. Fertil Steril. 2009;91(6):2281–94. https://doi.org/10.1016/j.fertnstert.2009.04.029.CrossRefPubMed

13.

Wu AK, Elliott P, Katz PP, Smith JF. Time costs of fertility care: the hidden hardship of building a family. Fertil Steril. 2013;99(7):2025–30. https://doi.org/10.1016/j.fertnstert.2013.01.145.CrossRefPubMedPubMedCentral

14.

Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003;18(9):1959–66.CrossRef

15.

Mol BW, Tjon-Kon-Fat R, Kamphuis E, van Wely M. Unexplained infertility: is it over-diagnosed and over-treated? Best Pract Res Clin Obstet Gynaecol. 2018;53:20–9. https://doi.org/10.1016/j.bpobgyn.2018.09.006.CrossRefPubMed

16.

Armstrong A, Plowden TC. Ethnicity and assisted reproductive technologies. Clin Pract (Lond). 2012;9(6):651–8. https://doi.org/10.2217/cpr.12.65.CrossRef

17.

Missmer SA, Seifer DB, Jain T. Cultural factors contributing to health care disparities among patients with infertility in Midwestern United States. Fertil Steril. 2011;95(6):1943–9. https://doi.org/10.1016/j.fertnstert.2011.02.039.CrossRefPubMed

18.

Seifer DB, Frazier LM, Grainger DA. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril. 2008;90(5):1701–10. https://doi.org/10.1016/j.fertnstert.2007.08.024.CrossRefPubMed

19.

Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci. 2015;8(4):191–6. https://doi.org/10.4103/0974-1208.170370.CrossRefPubMedPubMedCentral

20.

Culley L, Hudson N, Lohan M. Where are all the men? The marginalization of men in social scientific research on infertility. Reprod BioMed Online. 2013;27(3):225–35. https://doi.org/10.1016/j.rbmo.2013.06.009.CrossRefPubMed

21.

Meerabeau L. Husbands’ participation in fertility treatment: they also serve who only stand and wait. Sociol Health Illn. 1991;13(3):396–410. https://doi.org/10.1111/1467-9566.ep10492399.CrossRef

22.

Throsby K, Gill R. “It’s different for men”: masculinity and IVF. Men Masculinities. 2004;6(4):330–48. https://doi.org/10.1177/1097184x03260958.CrossRef

23.

Nachtigall RD, Becker G, Wozny M. The effects of gender-specific diagnosis on men’s and women’s response to infertility. Fertil Steril. 1992;57(1):113–21.CrossRef

24.

Tichenor V, McQuillan J, Greil AL, Contrepas R, Shreffler KM. The importance of fatherhood to U.S. married and cohabiting men. Fathering. 2011;9(3):232–51.CrossRef

25.

Marsiglio W, Hutchinson S, Cohan M. Young men’s procreative identity: becoming aware, being aware, and being responsible. J Marriage Fam. 2001;63(1):123–35. https://doi.org/10.1111/j.1741-3737.2001.00123.x.CrossRef

26.

Webb RE, Daniluk JC. The end of the line: infertile men’s experiences of being unable to produce a child. Men Masculinities. 1999;2(1):6–25. https://doi.org/10.1177/1097184x99002001002.CrossRef

27.

O'Donnell L, Stanton P, de Kretser DM. Endocrinology of the male reproductive system and spermatogenesis. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.

28.

Molina PE. Endocrine physiology. Fifth edition. ed. New York: McGraw-Hill Education; 2018.

29.

Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol. 2001;145(5):561–71.CrossRef

30.

Young B, Wheater PR. Wheater’s functional histology: a text and colour atlas. 5th ed. Oxford: Churchill Livingstone Elsevier; 2006.

31.

Borg CL, Wolski KM, Gibbs GM, O’Bryan MK. Phenotyping male infertility in the mouse: how to get the most out of a ‘non-performer’. Hum Reprod Update. 2010;16(2):205–24. https://doi.org/10.1093/humupd/dmp032.CrossRefPubMed

32.

•• Barratt CLR, Bjorndahl L, De Jonge CJ, Lamb DJ, Osorio Martini F, McLachlan R, et al. The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities. Hum Reprod Update. 2017;23(6):660–80. https://doi.org/10.1093/humupd/dmx021This article summarizes recommendations given to the World Health Organization regarding the highest priority questions about male infertility diagnostics. Evidence-based findings provide information about the prevalence of male infertility, semen parameters, evaluation requirements, and the impact of environmental exposures on fertility. CrossRefPubMedPubMedCentral

33.

Bieniek JM, Lo KC. Recent advances in understanding & managing male infertility. F1000Res. 2016;5:2756. https://doi.org/10.12688/f1000research.9375.1.CrossRefPubMedPubMedCentral

34.

Gudeloglu A, Parekattil SJ. Update in the evaluation of the azoospermic male. Clinics (Sao Paulo). 2013;68(Suppl 1):27–34.CrossRef

35.

•• Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society for Male Reproduction and Urology. Evaluation of the azoospermic male: a committee opinion. Fertil Steril. 2018;109(5):777–82. https://doi.org/10.1016/j.fertnstert.2018.01.043This document from the American Society for Reproductive Medicine provides specific diagnostic algorithms for obstructive and nonobstructive azoospermia to aid clinical decision making.

36.

Jedrzejczak P, Taszarek-Hauke G, Hauke J, Pawelczyk L, Duleba AJ. Prediction of spontaneous conception based on semen parameters. Int J Androl. 2008;31(5):499–507. https://doi.org/10.1111/j.1365-2605.2007.00799.x.CrossRefPubMed

37.

Macleod J, Gold RZ. The male factor in fertility and infertility. II. Spermatozoon counts in 1000 men of known fertility and in 1000 cases of infertile marriage. J Urol. 1951;66(3):436–49.CrossRef

38.

World Health Organization. WHO laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010.

39.

Cooper TG. Semen analysis. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Heidelberg: Springer; 2010. p. xvii–629.

40.

Alshahrani S, McGill J, Agarwal A. Prostatitis and male infertility. J Reprod Immunol. 2013;100(1):30–6. https://doi.org/10.1016/j.jri.2013.05.004.CrossRefPubMed

41.

Roberts M, Jarvi K. Steps in the investigation and management of low semen volume in the infertile man. Can Urol Assoc J. 2009;3(6):479–85.CrossRef

42.

Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, et al. European Association of Urology guidelines on male infertility: the 2012 update. Eur Urol. 2012;62(2):324–32. https://doi.org/10.1016/j.eururo.2012.04.048.CrossRefPubMed

43.

Simoni M, Nieschlag E. Endocrine laboratory diagnosis. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology: male reproductive health and dysfunction. 3rd ed. Heidelberg: Springer; 2010. p. xvii–629.

44.

McLachlan RI. Approach to the patient with oligozoospermia. J Clin Endocrinol Metab. 2013;98(3):873–80. https://doi.org/10.1210/jc.2012-3650.CrossRefPubMed

45.

Kolettis PN, Purcell ML, Parker W, Poston T, Nangia AK. Medical testosterone: an iatrogenic cause of male infertility and a growing problem. Urology. 2015;85(5):1068–73. https://doi.org/10.1016/j.urology.2014.12.052.CrossRefPubMed

46.

•• Okutman O, Rhouma MB, Benkhalifa M, Muller J, Viville S. Genetic evaluation of patients with non-syndromic male infertility. J Assist Reprod Genet. 2018;35(11):1939–51. https://doi.org/10.1007/s10815-018-1301-7This paper offers a clear work flow for genetic tests in male infertility. In addition, case studies are used to demonstrate effective responses to differential test results.

47.

Shah K, Sivapalan G, Gibbons N, Tempest H, Griffin DK. The genetic basis of infertility. Reproduction. 2003;126(1):13–25.CrossRef

48.

Olesen IA, Andersson AM, Aksglaede L, Skakkebaek NE, Rajpert-de Meyts E, Joergensen N, et al. Clinical, genetic, biochemical, and testicular biopsy findings among 1,213 men evaluated for infertility. Fertil Steril. 2017;107(1):74–82 e7. https://doi.org/10.1016/j.fertnstert.2016.09.015.CrossRefPubMed

49.

Krausz C, Riera-Escamilla A. Genetics of male infertility. Nat Rev Urol. 2018;15(6):369–84. https://doi.org/10.1038/s41585-018-0003-3.CrossRefPubMed

50.

• Tüttelmann F, Ruckert C, Ropke A. Disorders of spermatogenesis: perspectives for novel genetic diagnostics after 20 years of unchanged routine. Med Genet. 2018;30(1):12–20. https://doi.org/10.1007/s11825-018-0181-7This article calculates the prevalence of unexplained male infertility and recommends criteria for developing a male infertility gene panel. CrossRefPubMedPubMedCentral

51.

Yu J, Chen Z, Ni Y, Li Z. CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod. 2012;27(1):25–35. https://doi.org/10.1093/humrep/der377.

52.

Patat O, Pagin A, Siegfried A, Mitchell V, Chassaing N, Faguer S, et al. Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X-linked congenital bilateral absence of vas deferens. Am J Hum Genet. 2016;99(2):437–42. https://doi.org/10.1016/j.ajhg.2016.06.012.

53.

Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod BioMed Online. 2007;14(6):734–45.CrossRef

54.

Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933–43.

55.

Navarro-Costa P, Plancha CE, Goncalves J. Genetic dissection of the AZF regions of the human Y chromosome: thriller or filler for male (in)fertility? J Biomed Biotechnol. 2010;2010:936569. https://doi.org/10.1155/2010/936569.CrossRefPubMedPubMedCentral

56.

Krausz C, Casamonti E. Spermatogenic failure and the Y chromosome. Hum Genet. 2017;136(5):637–55. https://doi.org/10.1007/s00439-017-1793-8.CrossRefPubMed

57.

Massart A, Lissens W, Tournaye H, Stouffs K. Genetic causes of spermatogenic failure. Asian J Androl. 2012;14(1):40–8. https://doi.org/10.1038/aja.2011.67.CrossRefPubMed

58.

Kamp C, Huellen K, Fernandes S, Sousa M, Schlegel PN, Mielnik A, et al. High deletion frequency of the complete AZFa sequence in men with Sertoli-cell-only syndrome. Mol Hum Reprod. 2001;7(10):987–94.CrossRef

59.

Krausz C, Quintana-Murci L, McElreavey K. Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis? Hum Reprod. 2000;15(7):1431–4.CrossRef

60.

Rives N, Joly G, Machy A, Simeon N, Leclerc P, Mace B. Assessment of sex chromosome aneuploidy in sperm nuclei from 47,XXY and 46,XY/47,XXY males: comparison with fertile and infertile males with normal karyotype. Mol Hum Reprod. 2000;6(2):107–12.CrossRef

61.

Donker RB, Vloeberghs V, Groen H, Tournaye H, van Ravenswaaij-Arts CMA, Land JA. Chromosomal abnormalities in 1663 infertile men with azoospermia: the clinical consequences. Hum Reprod. 2017;32(12):2574–80. https://doi.org/10.1093/humrep/dex307.CrossRefPubMed

62.

Schiff JD, Palermo GD, Veeck LL, Goldstein M, Rosenwaks Z, Schlegel PN. Success of testicular sperm extraction [corrected] and intracytoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab. 2005;90(11):6263–7. https://doi.org/10.1210/jc.2004-2322.CrossRefPubMed

63.

Fullerton G, Hamilton M, Maheshwari A. Should non-mosaic Klinefelter syndrome men be labelled as infertile in 2009? Hum Reprod. 2010;25(3):588–97. https://doi.org/10.1093/humrep/dep431.CrossRefPubMed

64.

Vorona E, Zitzmann M, Gromoll J, Schuring AN, Nieschlag E. Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab. 2007;92(9):3458–65. https://doi.org/10.1210/jc.2007-0447.CrossRefPubMed

65.

de la Chapelle A. The etiology of maleness in XX men. Hum Genet. 1981;58(1):105–16.CrossRef

66.

Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, et al. Cytogenetics of infertile men. Hum Reprod. 1996;11(Suppl 4):1–24 discussion 25–6.

67.

Burgoyne PS, Mahadevaiah SK, Turner JM. The consequences of asynapsis for mammalian meiosis. Nat Rev Genet. 2009;10(3):207–16. https://doi.org/10.1038/nrg2505.CrossRefPubMed

68.

Homolka D, Ivanek R, Capkova J, Jansa P, Forejt J. Chromosomal rearrangement interferes with meiotic X chromosome inactivation. Genome Res. 2007;17(10):1431–7. https://doi.org/10.1101/gr.6520107.CrossRefPubMedPubMedCentral

69.

Vozdova M, Oracova E, Kasikova K, Prinosilova P, Rybar R, Horinova V, et al. Balanced chromosomal translocations in men: relationships among semen parameters, chromatin integrity, sperm meiotic segregation and aneuploidy. J Assist Reprod Genet. 2013;30(3):391–405. https://doi.org/10.1007/s10815-012-9921-9.

70.

Xie C, Chen X, Liu Y, Wu Z, Ping P. Multicenter study of genetic abnormalities associated with severe oligospermia and non-obstructive azoospermia. J Int Med Res. 2018;46(1):107–14. https://doi.org/10.1177/0300060517718771.CrossRefPubMed

71.

Brugnon F, Van Assche E, Verheyen G, Sion B, Boucher D, Pouly JL, et al. Study of two markers of apoptosis and meiotic segregation in ejaculated sperm of chromosomal translocation carrier patients. Hum Reprod. 2006;21(3):685–93. https://doi.org/10.1093/humrep/dei401.CrossRefPubMed

72.

Oliver-Bonet M, Navarro J, Codina-Pascual M, Abad C, Guitart M, Egozcue J, et al. From spermatocytes to sperm: meiotic behaviour of human male reciprocal translocations. Hum Reprod. 2004;19(11):2515–22. https://doi.org/10.1093/humrep/deh492.

73.

Kavalier F. Investigation of recurrent miscarriages. BMJ. 2005;331(7509):121–2. https://doi.org/10.1136/bmj.331.7509.121.CrossRefPubMedPubMedCentral

74.

Matzuk MM, Lamb DJ. Genetic dissection of mammalian fertility pathways. Nat Cell Biol. 2002;4(Suppl):s41–9. https://doi.org/10.1038/ncb-nm-fertilityS41.CrossRefPubMed

75.

• Oud MS, Volozonoka L, Smits RM, Vissers L, Ramos L, Veltman JA. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod. 2019;34(5):932–41. https://doi.org/10.1093/humrep/dez022This article uses Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and standardized clinical validity assessment to review male infertility genes.

76.

Fakhro KA, Elbardisi H, Arafa M, Robay A, Rodriguez-Flores JL, Al-Shakaki A, et al. Point-of-care whole-exome sequencing of idiopathic male infertility. Genet Med. 2018;20(11):1365–73. https://doi.org/10.1038/gim.2018.10.

77.

Tuttelmann F, Simoni M, Kliesch S, Ledig S, Dworniczak B, Wieacker P, et al. Copy number variants in patients with severe oligozoospermia and Sertoli-cell-only syndrome. PLoS One. 2011;6(4):e19426. https://doi.org/10.1371/journal.pone.0019426.CrossRefPubMedPubMedCentral

78.

Lo Giacco D, Chianese C, Ars E, Ruiz-Castane E, Forti G, Krausz C. Recurrent X chromosome-linked deletions: discovery of new genetic factors in male infertility. J Med Genet. 2014;51(5):340–4. https://doi.org/10.1136/jmedgenet-2013-101988.CrossRefPubMed

79.

Santi D, Spaggiari G, Simoni M. Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses. Reprod BioMed Online. 2018;37(3):315–26. https://doi.org/10.1016/j.rbmo.2018.06.023.CrossRefPubMed

80.

Simon L, Emery BR, Carrell DT. Review: Diagnosis and impact of sperm DNA alterations in assisted reproduction. Best Pract Res Clin Obstet Gynaecol. 2017;44:38–56. https://doi.org/10.1016/j.bpobgyn.2017.07.003.CrossRefPubMed

81.

Foresta C, Ferlin A, Moro E. Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet. 2000;9(8):1161–9.

82.

Gershoni M, Hauser R, Yogev L, Lehavi O, Azem F, Yavetz H, et al. A familial study of azoospermic men identifies three novel causative mutations in three new human azoospermia genes. Genet Med. 2017;19(9):998–1006. https://doi.org/10.1038/gim.2016.225.

83.

Kasak L, Punab M, Nagirnaja L, Grigorova M, Minajeva A, Lopes AM, et al. Bi-allelic recessive loss-of-function variants in FANCM cause non-obstructive azoospermia. Am J Hum Genet. 2018;103(2):200–12. https://doi.org/10.1016/j.ajhg.2018.07.005.CrossRefPubMedPubMedCentral

84.

Gou LT, Kang JY, Dai P, Wang X, Li F, Zhao S, et al. Ubiquitination-deficient mutations in human Piwi cause male infertility by impairing histone-to-protamine exchange during spermiogenesis. Cell. 2017;169(6):1090–104 e13. https://doi.org/10.1016/j.cell.2017.04.034.

85.

Yatsenko AN, Roy A, Chen R, Ma L, Murthy LJ, Yan W, et al. Non-invasive genetic diagnosis of male infertility using spermatozoal RNA: KLHL10 mutations in oligozoospermic patients impair homodimerization. Hum Mol Genet. 2006;15(23):3411–9. https://doi.org/10.1093/hmg/ddl417.

86.

Tenenbaum-Rakover Y, Weinberg-Shukron A, Renbaum P, Lobel O, Eideh H, Gulsuner S, et al. Minichromosome maintenance complex component 8 (MCM8) gene mutations result in primary gonadal failure. J Med Genet. 2015;52(6):391–9. https://doi.org/10.1136/jmedgenet-2014-102921.

87.

Miyamoto T, Bando Y, Koh E, Tsujimura A, Miyagawa Y, Iijima M, et al. A PLK4 mutation causing azoospermia in a man with Sertoli cell-only syndrome. Andrology. 2016;4(1):75–81. https://doi.org/10.1111/andr.12113.CrossRefPubMed

88.

Kherraf ZE, Christou-Kent M, Karaouzene T, Amiri-Yekta A, Martinez G, Vargas AS, et al. SPINK2 deficiency causes infertility by inducing sperm defects in heterozygotes and azoospermia in homozygotes. EMBO Mol Med. 2017;9(8):1132–49. https://doi.org/10.15252/emmm.201607461.CrossRefPubMedPubMedCentral

89.

Maor-Sagie E, Cinnamon Y, Yaacov B, Shaag A, Goldsmidt H, Zenvirt S, et al. Deleterious mutation in SYCE1 is associated with non-obstructive azoospermia. J Assist Reprod Genet. 2015;32(6):887–91. https://doi.org/10.1007/s10815-015-0445-y.

90.

• Schilit SLP, Menon S, Friedrich C, Kammin T, Wilch E, Hanscom C et al. SYCP2 translocation-mediated dysregulation and frameshift variants cause human male infertility. bioRxiv. 2019:641928. https://doi.org/10.1101/641928.This article provides evidence that disrupted or potentially dysregulated genes by rearrangement breakpoints should be evaluated for causality in infertile males with BCAs.

91.

Miyamoto T, Hasuike S, Yogev L, Maduro MR, Ishikawa M, Westphal H, et al. Azoospermia in patients heterozygous for a mutation in SYCP3. Lancet. 2003;362(9397):1714–9. https://doi.org/10.1016/S0140-6736(03)14845-3.CrossRefPubMed

92.

Ayhan O, Balkan M, Guven A, Hazan R, Atar M, Tok A, et al. Truncating mutations in TAF4B and ZMYND15 causing recessive azoospermia. J Med Genet. 2014;51(4):239–44. https://doi.org/10.1136/jmedgenet-2013-102102.

93.

Tan YQ, Tu C, Meng L, Yuan S, Sjaarda C, Luo A, et al. Loss-of-function mutations in TDRD7 lead to a rare novel syndrome combining congenital cataract and nonobstructive azoospermia in humans. Genet Med. 2019;21(5):1209-17. https://doi.org/10.1038/gim.2017.130.

94.

Arafat M, Har-Vardi I, Harlev A, Levitas E, Zeadna A, Abofoul-Azab M, et al. Mutation in TDRD9 causes non-obstructive azoospermia in infertile men. J Med Genet. 2017;54(9):633–9. https://doi.org/10.1136/jmedgenet-2017-104514.

95.

Yang F, Silber S, Leu NA, Oates RD, Marszalek JD, Skaletsky H, et al. TEX11 is mutated in infertile men with azoospermia and regulates genome-wide recombination rates in mouse. EMBO Mol Med. 2015;7(9):1198–210. https://doi.org/10.15252/emmm.201404967.CrossRefPubMedPubMedCentral

96.

Yatsenko AN, Georgiadis AP, Ropke A, Berman AJ, Jaffe T, Olszewska M, et al. X-linked TEX11 mutations, meiotic arrest, and azoospermia in infertile men. N Engl J Med. 2015;372(22):2097–107. https://doi.org/10.1056/NEJMoa1406192.CrossRefPubMedPubMedCentral

97.

Colombo R, Pontoglio A, Bini M. Two novel TEX15 mutations in a family with nonobstructive azoospermia. Gynecol Obstet Investig. 2017;82(3):283-6. https://doi.org/10.1159/000468934.

98.

Yang Y, Guo J, Dai L, Zhu Y, Hu H, Tan L, et al. XRCC2 mutation causes meiotic arrest, azoospermia and infertility. J Med Genet. 2018;55(9):628–36. https://doi.org/10.1136/jmedgenet-2017-105145.

99.

Zhang YX, Li HY, He WB, Tu C, Du J, Li W, et al. XRCC2 mutation causes premature ovarian insufficiency as well as non-obstructive azoospermia in humans. Clin Genet. 2019;95(3):442-3. https://doi.org/10.1111/cge.13475.

100.

Zhu F, Liu C, Wang F, Yang X, Zhang J, Wu H, et al. Mutations in PMFBP1 cause acephalic spermatozoa syndrome. Am J Hum Genet. 2018;103(2):188–99. https://doi.org/10.1016/j.ajhg.2018.06.010.

101.

Zhu F, Wang F, Yang X, Zhang J, Wu H, Zhang Z, et al. Biallelic SUN5 mutations cause autosomal-recessive acephalic spermatozoa syndrome. Am J Hum Genet. 2016;99(6):1405. https://doi.org/10.1016/j.ajhg.2016.11.002.

102.

Avenarius MR, Hildebrand MS, Zhang Y, Meyer NC, Smith LL, Kahrizi K, et al. Human male infertility caused by mutations in the CATSPER1 channel protein. Am J Hum Genet. 2009;84(4):505–10. https://doi.org/10.1016/j.ajhg.2009.03.004.CrossRefPubMedPubMedCentral

103.

Dirami T, Rode B, Jollivet M, Da Silva N, Escalier D, Gaitch N, et al. Missense mutations in SLC26A8, encoding a sperm-specific activator of CFTR, are associated with human asthenozoospermia. Am J Hum Genet. 2013;92(5):760–6. https://doi.org/10.1016/j.ajhg.2013.03.016.CrossRefPubMedPubMedCentral

104.

Harbuz R, Zouari R, Pierre V, Ben Khelifa M, Kharouf M, Coutton C, et al. A recurrent deletion of DPY19L2 causes infertility in man by blocking sperm head elongation and acrosome formation. Am J Hum Genet. 2011;88(3):351–61. https://doi.org/10.1016/j.ajhg.2011.02.007.

105.

Zhu F, Gong F, Lin G, Lu G. DPY19L2 gene mutations are a major cause of globozoospermia: identification of three novel point mutations. Mol Hum Reprod. 2013;19(6):395–404. https://doi.org/10.1093/molehr/gat018.CrossRefPubMed

106.

Dam AH, Koscinski I, Kremer JA, Moutou C, Jaeger AS, Oudakker AR, et al. Homozygous mutation in SPATA16 is associated with male infertility in human globozoospermia. Am J Hum Genet. 2007;81(4):813–20. https://doi.org/10.1086/521314.

107.

Dieterich K, Soto Rifo R, Faure AK, Hennebicq S, Ben Amar B, Zahi M, et al. Homozygous mutation of AURKC yields large-headed polyploid spermatozoa and causes male infertility. Nat Genet. 2007;39(5):661–5. https://doi.org/10.1038/ng2027.

108.

Coutton C, Martinez G, Kherraf ZE, Amiri-Yekta A, Boguenet M, Saut A, et al. Bi-allelic mutations in ARMC2 lead to severe astheno-teratozoospermia due to sperm flagellum malformations in humans and mice. Am J Hum Genet. 2019;104(2):331-40 https://doi.org/10.1016/j.ajhg.2018.12.013.

109.

Tang S, Wang X, Li W, Yang X, Li Z, Liu W, et al. Biallelic mutations in CFAP43 and CFAP44 cause male infertility with multiple morphological abnormalities of the sperm flagella. Am J Hum Genet. 2017;100(6):854–64. https://doi.org/10.1016/j.ajhg.2017.04.012.

110.

Dong FN, Amiri-Yekta A, Martinez G, Saut A, Tek J, Stouvenel L, et al. Absence of CFAP69 causes male infertility due to multiple morphological abnormalities of the flagella in human and mouse. Am J Hum Genet. 2018;102(4):636–48. https://doi.org/10.1016/j.ajhg.2018.03.007.

111.

Ben Khelifa M, Coutton C, Zouari R, Karaouzene T, Rendu J, Bidart M, et al. Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella. Am J Hum Genet. 2014;94(1):95–104. https://doi.org/10.1016/j.ajhg.2013.11.017.CrossRefPubMedPubMedCentral

112.

Wang X, Jin H, Han F, Cui Y, Chen J, Yang C, et al. Homozygous DNAH1 frameshift mutation causes multiple morphological anomalies of the sperm flagella in Chinese. Clin Genet. 2017;91(2):313–21. https://doi.org/10.1111/cge.12857.

113.

Imtiaz A, Belyantseva IA, Beirl AJ, Fenollar-Ferrer C, Bashir R, Bukhari I, et al. CDC14A phosphatase is essential for hearing and male fertility in mouse and human. Hum Mol Genet. 2018;27(5):780–98. https://doi.org/10.1093/hmg/ddx440.CrossRefPubMed

114.

Kuo YC, Lin YH, Chen HI, Wang YY, Chiou YW, Lin HH, et al. SEPT12 mutations cause male infertility with defective sperm annulus. Hum Mutat. 2012;33(4):710–9. https://doi.org/10.1002/humu.22028.

115.

Lin YH, Wang YY, Chen HI, Kuo YC, Chiou YW, Lin HH, et al. SEPTIN12 genetic variants confer susceptibility to teratozoospermia. PLoS One. 2012;7(3):e34011. https://doi.org/10.1371/journal.pone.0034011.

116.

Escoffier J, Lee HC, Yassine S, Zouari R, Martinez G, Karaouzene T, et al. Homozygous mutation of PLCZ1 leads to defective human oocyte activation and infertility that is not rescued by the WW-binding protein PAWP. Hum Mol Genet. 2016;25(5):878–91. https://doi.org/10.1093/hmg/ddv617.CrossRefPubMed

117.

Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, et al. Evaluating the clinical validity of gene-disease associations: an evidence-based framework developed by the clinical genome resource. Am J Hum Genet. 2017;100(6):895–906. https://doi.org/10.1016/j.ajhg.2017.04.015.

118.

Mitchell MJ, Metzler-Guillemain C, Toure A, Coutton C, Arnoult C, Ray PF. Single gene defects leading to sperm quantitative anomalies. Clin Genet. 2017;91(2):208–16. https://doi.org/10.1111/cge.12900.CrossRefPubMed

119.

Nakamura S, Miyado M, Saito K, Katsumi M, Nakamura A, Kobori Y, et al. Nextgeneration sequencing for patients with non-obstructive azoospermia: implications for significant roles of monogenic/oligogenic mutations. Andrology. 2017; 5(4):824-831.https://doi.org/10.1111/andr.12378.

120.

Robay A, Abbasi S, Akil A, El-Bardisi H, Arafa M, Crystal RG, et al. A systematic review on the genetics of male infertility in the era of next-generation sequencing. Arab J Urol. 2018;16(1):53–64. https://doi.org/10.1016/j.aju.2017.12.003.CrossRefPubMedPubMedCentral

121.

Patel B, Parets S, Akana M, Kellogg G, Jansen M, Chang C, et al. Comprehensive genetic testing for female and male infertility using next-generation sequencing. J Assist Reprod Genet. 2018;35(8):1489–96. https://doi.org/10.1007/s10815-018-1204-7.

122.

Vendrell X. New genetic point mutations in male infertility. In: Horcajadas JA, Gosálvez J, editors. Reproductomics: the -omics revolution and its impact on human reproductive medicine. London: Elsevier/Academic Press; 2018. p. 47–62.CrossRef

123.

Higgins AW, Alkuraya FS, Bosco AF, Brown KK, Bruns GA, Donovan DJ, et al. Characterization of apparently balanced chromosomal rearrangements from the developmental genome anatomy project. Am J Hum Genet. 2008;82(3):712–22. https://doi.org/10.1016/j.ajhg.2008.01.011.

124.

Schilit SL, Currall BB, Yao R, Hanscom C, Collins RL, Pillalamarri V, et al. Estrogen-related receptor gamma implicated in a phenotype including hearing loss and mild developmental delay. Eur J Hum Genet. 2016;24(11):1622–6. https://doi.org/10.1038/ejhg.2016.64.

125.

Currall BB, Chen M, Sallari RC, Cotter M, Wong KE, Robertson NG, et al. Loss of LDAH associated with prostate cancer and hearing loss. Hum Mol Genet. 2018;27(24):4194–203. https://doi.org/10.1093/hmg/ddy310.

126.

Wilch ES, Morton CC. Historical and clinical perspectives on chromosomal translocations. In: Zhang Y, editor. Chromosome translocation. Singapore: Springer Singapore; 2018. p. 1–14.

127.

Mukherjee K, Ishii K, Pillalamarri V, Kammin T, Atkin JF, Hickey SE, et al. Actin capping protein CAPZB regulates cell morphology, differentiation, and neural crest migration in craniofacial morphogenesisdagger. Hum Mol Genet. 2016;25(7):1255–70. https://doi.org/10.1093/hmg/ddw006.CrossRefPubMedPubMedCentral

128.

Redin C, Brand H, Collins RL, Kammin T, Mitchell E, Hodge JC, et al. The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. Nat Genet. 2017;49(1):36–45. https://doi.org/10.1038/ng.3720.CrossRefPubMed

129.

Lindgren AM, Hoyos T, Talkowski ME, Hanscom C, Blumenthal I, Chiang C, et al. Haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palate. Hum Genet. 2013;132(5):537–52. https://doi.org/10.1007/s00439-013-1263-x.

130.

Kim HG, Kim HT, Leach NT, Lan F, Ullmann R, Silahtaroglu A, et al. Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. Am J Hum Genet. 2012;91(1):56–72. https://doi.org/10.1016/j.ajhg.2012.05.005.

131.

Lachke SA, Higgins AW, Inagaki M, Saadi I, Xi Q, Long M, et al. The cell adhesion gene PVRL3 is associated with congenital ocular defects. Hum Genet. 2012;131(2):235–50. https://doi.org/10.1007/s00439-011-1064-z.

132.

Brown KK, Reiss JA, Crow K, Ferguson HL, Kelly C, Fritzsch B, et al. Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35). Hum Genet. 2010;127(1):19–31. https://doi.org/10.1007/s00439-009-0736-4.

133.

Ray PF, Toure A, Metzler-Guillemain C, Mitchell MJ, Arnoult C, Coutton C. Genetic abnormalities leading to qualitative defects of sperm morphology or function. Clin Genet. 2017;91(2):217–32. https://doi.org/10.1111/cge.12905.CrossRefPubMed

134.

Rybouchkin AV, Van der Straeten F, Quatacker J, De Sutter P, Dhont M. Fertilization and pregnancy after assisted oocyte activation and intracytoplasmic sperm injection in a case of round-headed sperm associated with deficient oocyte activation capacity. Fertil Steril. 1997;68(6):1144–7.CrossRef

135.

Kochhar PK, Ghosh P. Intracytoplasmic sperm injection with assisted oocyte activation resulting in successful pregnancies and live birth in couples with globozoospermia: a report of two cases. J Hum Reprod Sci. 2018;11(1):72–4. https://doi.org/10.4103/jhrs.JHRS_47_17.CrossRefPubMedPubMedCentral

Titel: Recent Advances and Future Opportunities to Diagnose Male Infertility
verfasst von: Samantha L. P. Schilit
Publikationsdatum: 26.10.2019
Verlag: Springer US
Erschienen in: Current Sexual Health Reports / Ausgabe 4/2019
Print ISSN: 1548-3584
Elektronische ISSN: 1548-3592
DOI: https://doi.org/10.1007/s11930-019-00225-8

Neu im Fachgebiet Urologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Recent Advances and Future Opportunities to Diagnose Male Infertility

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Sexuality and Intimacy Among Older Women Living with HIV: a Systematic Review

Interactions Between Inflammation and Female Sexual Desire and Arousal Function

The Significance of Sexual Debut in Women’s Lives

The Gut Microbiome and Men’s Sexual Health

Management of the Acute Phase of Peyronie’s Disease: a Contemporary Review

Sexual and Gender Identity Development in Young Adults and Implications for Healthcare

Neu im Fachgebiet Urologie

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Update Urologie